Historical salary details - Dr. Mikael Dolsten, M.D.,PhD, Chief Scientific Officer and President, Pfizer Research and Development, Pfizer Inc.
Dr. Mikael Dolsten, M.D.,PhD has been the Chief Scientific Officer and President, Pfizer Research and Development of Pfizer Inc. since 17 Oct 2008 and his latest salary was 9.7 M. View his historical salary.
Dr. Mikael Dolsten, M.D.,Phd
Chief Scientific Officer and President, Pfizer Research and Development
$ 9.7 M
Gross Remuneration
-
Current Company
Pfizer Inc.
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Pfizer Inc. | Chief Scientific Officer and President, Pfizer Research and Development | 9.7 M | - |
| 2023 | Pfizer Inc. | Chief Scientific Officer and President, Pfizer Research and Development | 8.9 M | -27.5 % |
| 2023 | Pfizer Inc. | Chief Scientific Officer and President, Pfizer Research and Development | - | - |
| 2022 | Pfizer Inc. | Chief Scientific Officer and President, Worldwide Research, Development and Medical | 12.2 M | 11.9 % |
| 2021 | Pfizer Inc. | - | 10.9 M | 7.5 % |
| 2021 | Pfizer Inc. | Chief Scientific Officer and President, Worldwide Research, Development and Medical | 10.9 M | 7.5 % |
| 2020 | Pfizer Inc. | - | 10.1 M | 5.7 % |
| 2020 | Pfizer Inc. | Chief Scientific Officer and President, Worldwide Research, Development and Medical | 10.1 M | 5.7 % |
| 2020 | Pfizer Inc. | - | 10.1 M | 5.7 % |
| 2019 | Pfizer Inc. | - | 9.6 M | 35.8 % |
| 2019 | Pfizer Inc. | Chief Scientific Officer and President, Worldwide Research, Development, Medical | 9.6 M | 35.8 % |
| 2019 | Pfizer Inc. | - | 9.6 M | 35.8 % |
| 2018 | Pfizer Inc. | - | 7.1 M | -7.8 % |
| 2018 | Pfizer Inc. | - | 7.1 M | -7.8 % |
| 2018 | Pfizer Inc. | Chief Scientific Officer, President, Worldwide Research, Development and Medical | 7.1 M | -7.8 % |
| 2017 | Pfizer Inc. | - | 7.7 M | -6.8 % |
| 2017 | Pfizer Inc. | President, Worldwide Research & Development | 7.7 M | -6.8 % |
| 2017 | Pfizer Inc. | - | 7.7 M | -6.8 % |
| 2016 | Pfizer Inc. | - | 8.2 M | 35.8 % |
| 2016 | Pfizer Inc. | President, Worldwide Research and Development | 8.2 M | 35.8 % |
| 2016 | Pfizer Inc. | - | 8.2 M | 35.8 % |
| 2015 | Pfizer Inc. | - | 6.1 M | -16.7 % |
| 2015 | Pfizer Inc. | - | 6.1 M | -16.7 % |
| 2015 | Pfizer Inc. | President, Worldwide Research and Development | 6.1 M | -16.7 % |
| 2014 | Pfizer Inc. | - | 7.3 M | 12.7 % |
| 2014 | Pfizer Inc. | President, Worldwide Research and Development | 7.3 M | 12.7 % |
| 2014 | Pfizer Inc. | - | 7.3 M | 12.7 % |
| 2013 | Pfizer Inc. | - | 6.5 M | -5.6 % |
| 2013 | Pfizer Inc. | President, Worldwide Research and Development | 6.5 M | -5.6 % |
| 2013 | Pfizer Inc. | - | 6.5 M | -5.6 % |
| 2012 | Pfizer Inc. | - | 6.8 M | -2.0 % |
| 2012 | Pfizer Inc. | President of Worldwide Research and Development | 6.8 M | -2.0 % |
| 2012 | Pfizer Inc. | - | 6.8 M | -2.0 % |
| 2011 | Pfizer Inc. | - | 7.0 M | 18.2 % |
| 2011 | Pfizer Inc. | - | 7.0 M | 18.2 % |
| 2011 | Pfizer Inc. | President of Worldwide Research and Development | 7.0 M | 18.2 % |
| 2010 | Pfizer Inc. | - | 5.9 M | - |
| 2010 | Pfizer Inc. | - | 5.9 M | - |
| 2010 | Pfizer Inc. | President of Worldwide Research and Development | 5.9 M | - |
| 2009 | Pfizer Inc. | Senior Vice President; President, Pfizer BioTherapeutics Research & Development Group | - | - |